ARCHIVED - Formative Evaluation of the Canadian HIV Vaccine Initiative
Management Response and Action Plan
Evaluation Recommendations | Management Response | Management Action Plan | Deliverables | Expected Completion Date | Responsibility | Accountability | Resources | |
---|---|---|---|---|---|---|---|---|
1 | The Interdepartmental Steering Committee take the opportunity of the recommendation of the Government of Canada and the Bill & Melinda Gates Foundation to not proceed with the Pilot Scale Manufacturing Capacity for Clinical Trial Lots component to re-examine the nature and scope of the Initiative and, as individual departments/ agencies, to re-examine their commitments to, and roles in, the Initiative, as well as the role of the Bill & Melinda Gates Foundation. | Agree | Interdepartmental Steering Committee to discuss the goals and objectives of the CHVI and the roles and responsibilities of the participating departments/ agencies and the Bill & Melinda Gates Foundation. | Decision outlining specific responsibilities regarding nature and scope of the Initiative, and the roles of the individual departments/agencies and the Bill & Melinda Gates Foundation. | December 2010 - June 2011 | The Director Generals of each of the partnering departments (CIDA, PHAC, Industry, CIHR, Health Canada). | Director General, Centre for Communicable Diseases and Infection Control, PHAC | N/A. The tasks will be consumed within the current funding and delivery practice. |
2 | The Interdepartmental Steering Committee seek an extension to the Initiative beyond 2012/13, ensuring that there is sufficient flexibility in the Initiative to allow it to remain consistent over time with the global efforts to achieve an HIV vaccine. | Agree | Interdepartmental Steering Committee to seek authorities to extend the initiative. | Decision regarding an extension of the CHVI. | December 2010 | Director General, CCDIC, PHAC | Director General, Centre for Communicable Diseases and Infection Control, PHAC | TBD |
3 | As part of the re-examination of the nature and scope of the Initiative, the Interdepartmental Steering Committee identify clear expectations and timelines with respect to the delivery responsibilities of the participating departments/ agencies in order to overcome the factors that have contributed to the delays to date in the Initiative. | Agree | Interdepartmental Steering Committee to address implementation issues that resulted in delays and put in place measures to mitigate those issues (i.e. lack of explicit agreements between departments/ agencies regarding implementation, lack of engagement of some stakeholders, high staff turnover in some depts.) |
Action plan | December 2010 | The Director Generals of each of the partnering departments (CIDA, PHAC, Industry, CIHR, Health Canada). | Director General, Centre for Communicable Diseases and Infection Control, PHAC | N/A. The tasks will be consumed within the current funding and delivery practice. |
4 | The Interdepartmental Steering Committee put in place measures to communicate effectively with external stakeholders, through both the CHVI website and clear messaging from the participating departments/ agencies. | Agree | Development of a Communications Engagement Strategy | Communications Engagement Strategy | December 2010 | The Director Generals of each of the partnering departments (CIDA, PHAC, Industry, CIHR, Health Canada). | Director General, Centre for Communicable Diseases and Infection Control, PHAC | N/A. The tasks will be consumed within the current funding and delivery practice. |
5 | The Interdepartmental Steering Committee re-examine the structure of the CHVI governing bodies, notably the Interdepartmental Steering Committee, to ensure that there is adequate authority and capacity to provide the necessary interdepartmental leadership. | Agree | Interdepartmental Steering Committee and Bill & Melinda Gates Foundation to review the governance structure and identify recommendations for the future. | Revised governance structure | December 2010 | The Director Generals of each of the partnering departments (CIDA, PHAC, Industry, CIHR, Health Canada) | Director General, Centre for Communicable Diseases and Infection Control, PHAC |
N/A. The tasks will be consumed within the current funding and delivery practice. |
6 | The Secretariat, working with the program-level Interdepartmental Committee, review the existing RMAF/RBAF to ensure that it remains relevant and clearly identifies departments/ agencies responsibilities for all components to the outcomes; and ensure that the RMAF/RBAF is implemented to provide sufficient data for the next evaluation. | Agree. | Review existing RMAF/RBAF and identify areas to be improved | Revised performance measurement framework | March 2011 | Director, CHVI Secretariat (PHAC) | Director General, Centre for Communicable Diseases and Infection Control, PHAC | N/A. The tasks will be consumed within the current funding and delivery practice. |
Page details
- Date modified: